Related Experiment Videos
The sepsis-coagulant axis: a review
1Department of Veterinary PathoBiology, Colege of Veterinary Medicine, University of Minnesota, St. Paul 55108, USA. weiss005@maroon.tc.umn.edu
Journal of Veterinary Internal Medicine
|October 17, 1998
Summary
Inflammation activates coagulation, leading to disseminated intravascular coagulation (DIC) and organ failure in sepsis. Current treatments are ineffective, but new drugs show promise.
Area of Science:
- Biomedical Science
- Hematology
- Inflammation Research
Background:
- Coagulation activation is a normal part of the inflammatory response.
- Inflammatory cytokines shift endothelium to a prothrombotic state, activating coagulation and platelets.
- Initial fibrinolytic activation is followed by inhibition, creating a procoagulant state.
Purpose of the Study:
- To explain the mechanisms of coagulation activation during inflammation.
- To describe the pathophysiology of disseminated intravascular coagulation (DIC) in sepsis.
- To review current and emerging treatments for DIC.
Main Methods:
- Review of inflammatory and coagulation pathways.
- Analysis of the imbalance between coagulation and fibrinolysis.
- Discussion of the role of DIC in sepsis-induced organ failure.
Main Results:
- Inflammatory cytokines promote a procoagulant state by altering endothelial function and activating coagulation factors.
- A net procoagulant state results from the imbalance between coagulation and fibrinolysis.
- Disseminated intravascular coagulation (DIC) arises when coagulation and platelet activation overwhelm regulatory mechanisms.
Conclusions:
- DIC is a critical factor in sepsis-related multiple organ failure and mortality.
- Existing treatments like heparin and aspirin have limited efficacy in managing DIC.
- Novel, more potent therapeutic agents for DIC are anticipated for clinical use.